Hogan announced Dr. Robert Redfield, former director of the Centers for Disease Control and Prevention, will join Maryland’s COVID-19 team, and provided updates about the Johnson & Johnson vaccine and more mass vaccination sites.
Vaccine
Governor’s Briefing on COVID-19: February 23, 2021
Another mass vaccination site set and a pre-registration website coming next month, nearly 30k shots now administered each day, increasing reports of fraud surrounding the vaccine, and additional screening for COVID-19 variants.
Governor Larry Hogan’s State of the State 2021
On Wednesday, February 3, 2021, Governor Larry Hogan live-streamed his State of the State address from the State House in Annapolis.
Governor’s Briefing on COVID-19: January 26, 2021
While supply continues to be limited with only 10,000 doses available each day, Hogan is expanding Phase 1 of vaccine distribution to include those who are severely immunocompromised. Mobile clinics and mass vaccination sites with National Guard support are coming soon.
Governor Hogan Press Conference: January 21, 2021
With experts insisting that in-person instruction does not increase community spread or hospitalizations, and COVID-19 numbers beginning to plateau since introduction of the vaccine, Governor Hogan urges schools to get kids in classrooms no later than March 1.
Governor’s Briefing on COVID-19: January 14, 2021
Governor Hogan announced an expedited rollout of the vaccine in Maryland – moving Phase 1B up to Monday 1/18 for ages 75+, assisted living residents and adding K-12 teachers, staff and child care providers. Phase 1C (ages 65-74) to begin Monday 1/25.
Latest Insights
View All
CTA Update: New Deadline Now in Effect
BOI reporting requirements under the CTA are back in effect. The new deadline for most reporting companies is now March 21, 2025.
Trade Secrets and MedTech: IP in the News
The decision in a lawsuit involving Insulet’s Omnipod insulin pumps provides a vivid reminder on the value of trade secrets and the need to protect them.
MedTech M&A is Poised for Growth
In MedTech Dive, Nemphos Braue highlights 5 reasons why healthcare mergers, acquisitions, JVs and other transactions – especially in the MedTech space – are poised to increase.
